News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

MHRA Alert – Fezolinetant (Veoza): Liver Injury Risk & Monitoring Guidance

Drug Safety Update: Fezolinetant (Veoza) The MHRA has issued new safety recommendations for fezolinetant (Veoza) following reports of drug-induced liver injury in patients receiving this treatment. Healthcare providers should be aware of this risk and implement appropriate monitoring protocols. Key Points Fezolinetant treatment carries a documented risk of drug-induced liver injury New recommendations have been […]